- Home
- SEGG vs BFRI Comparison
SEGG vs BFRI Comparison
Compare SEGG & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEGG | BFRI |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 16.3M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SEGG | BFRI |
|---|---|---|
| Price | $2.91 | $1.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $20.00 | $2.75 |
| AVG Volume (30 Days) | 40.5K | ★ 625.4K |
| Earning Date | 05-20-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.56 | 67.70 |
| EPS | N/A | ★ N/A |
| Revenue | $6,779,057.00 | ★ $41,705,000.00 |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $0.42 | $0.57 |
| 52 Week High | $5.80 | $1.66 |
Technical Indicators
Market Signals| Indicator | SEGG | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 59.93 | 50.04 |
| Support Level | $2.34 | $0.78 |
| Resistance Level | $3.12 | N/A |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 43.01 | 20.51 |
Price Performance
Historical ComparisonAbout SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is operated as a single-reporting unit focused on its lottery and gaming platform, and its organizational structure, internal reporting systems, and resource allocation processes were aligned accordingly.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.